News and Trends—November 2011

| November 21, 2011

The ASMBS Releases Updated Position Statement on Sleeve Gastrectomy as a Bariatric Procedure
GAINESVILLE, Florida—The American Society for Metabolic and Bariatric Surgery (ASMBS) has previously published two position statements on the use of sleeve gastrectomy (SG) as a bariatric procedure.1,2 These position statements were developed in response to inquiries made to the society by patients, physicians, hospitals, health insurance payers, the media, and others regarding new procedures or issues within our specialty that require close evaluation and evidence-based scrutiny. In the evolving field of bariatric surgery, it is periodically necessary to provide updated position statements based on a growing or changing body of evidence.

The Clinical Issues Committee and Executive Council have determined that since the 2009 position statement on SG was issued, there have been substantial changes to the published literature regarding SG and that the number and quality of the publications evaluating SG warrant publication of an updated statement. Specifically, multiple studies evaluating comorbidity improvement after SG, comparative studies with other accepted bariatric procedures, and longterm outcome data have emerged since the 2009 position statement.

Please visit to read the full statement.

Obesity Action Coalition (OAC) Unveils “Bias Busters” to Combat Weight Bias
and Stigma

TAMPA, Florida—The Obesity Action Coalition (OAC) unveiled a new initiative to combat weight bias and stigma, titled Bias Busters. “Weight bias and discrimination create significant obstacles for individuals affected by obesity. From weight bias in healthcare settings to pop culture, these individuals are often targets of unfair, disrespectful treatment because of their weight. No other disease is the focus of discrimination as well as jokes, ridicule or humor,” said Joe Nadglowski, OAC President and CEO.

The goal of Bias Busters is to engage the public in the conversation of weight bias and stigma, and raise awareness of the prevalence of the issue in today’s society. Bias Busters will highlight examples of weight bias that emerge in the news and media, and provide individuals with an opportunity to respond and let their voices be heard. Bias Busters also provides information about the nature and extent of weight bias and invites the public to share their own examples of bias with the OAC through biasbusters@obesity

For more information on Bias Busters, visit

To join the OAC and become a Bias Buster, please visit, contact the OAC National Office at (800) 717-3117, or e-mail

Ethicon Endo-Surgery Introduces First Powered Endocutter with Enhanced System-Wide Compression and Stability, Allowing Surgeons Greater Control in Laparoscopic Surgery

CINCINATTI, Ohio— Ethicon Endo-Surgery, Inc. (EES), announced the launch of the Echelon Flex™ Powered Endopath® Stapler—the industry’s first powered endocutter with enhanced system-wide compression and stability. Developed in collaboration with surgeons worldwide, the Powered Echelon Flex Stapler allows greater instrument stability with at least 63-percent reduction in tip movement during tissue cutting and stapling compared to the Endo GIA Ultra and the Endo GIA Universal. The Echelon Flex Powered Endopath Stapler will initially be available in a 60mm length.

For more information and to view videos of the Powered Echelon Flex Stapler in use, please visit:

For more information on EES visit

United States Bariatric (Obesity) Surgical Devices Market to Reach $2.6 Billion by 2017, According to a New Report by Global Industry Analysts, Inc.
San Jose, California (PRWEB)—Global Industry Analysts (GIA), Inc. announcedthe release of a comprehensive report on the United States Bariatric (Obesity) Surgical Devices markets. The US market for bariatric (obesity) surgical devices is projected to reach US$2.6 billion by 2017. Continuous rise in the number of obese individuals among adults as well as children is driving the demand for bariatric surgeries and devices. Increasing success rate of the surgeries, advent of sophisticated technologies, and improved reimbursement coverage are factors contributing to the growth of bariatric surgical devices market.

The economic crisis and rising healthcare costs led to a slow down in the number of bariatric surgeries being performed in the US. However, the alarming increase in the number of obese patients—as seen by the fact that about 35% of adults and over 15% of children are obese—presents favorable prospects for the adoption of bariatric surgery procedural volume.

Growing use of laparoscopic adjustable gastric banding systems and the emergence of new incisionless technologies such as intragastric balloons are expected to fuel market growth. New emergent technologies such as transorally inserted weight loss devices, vagal blocking systems, as and implantable gastric stimulators are also expected to benefit overall market. The Gastric Banding Devices market in the United States is expected to witness rapid growth despite the global economic crisis, driven by the increased availability of results proving the device’s long-term efficacy and safety.

To read more, visit

Covidien Launches World’s First NonAbsorbable, Uni-Directional Knotless Suture
Latest addition to the V-Loc™ wound closure device family unveiled at American College of Surgeons’ 97th Annual Clinical Congress

SAN FRANCISCO, California (BUSINESS WIRE)—Covidien, a global provider of healthcare products, announced the launch of the first nonabsorbable, uni-directional barbed suture, part of its family of V-Loc™ wound closure devices.

The V-Loc PBT (Polybutester) nonabsorbable wound closure device allows surgeons to securely close incisions without the need to tie knots. Nonabsorbable sutures are used to permanently close internal and external wounds. The V-Loc PBT joins the V-Loc 90 and V-Loc 180 absorbable wound closure devices currently available to healthcare professionals.

“The V-Loc PBT device allows for accurate oversewing of all staple lines, in both bariatric and general surgery cases,” said David Kim, MD, FACS, FASMBS, Forest Park Medical Center, Dallas. The V-Loc 180 device, launched in October 2009, was the first surgical device of its kind to feature uni-directional barbed suture technology. The V-Loc PBT non-absorbable wound closure device has been cleared for one-time use by the United States Food and Drug Administration and is currently available in the U.S.

To read the full release, please visit

To learn more about Covidien, please visit.

Microline surgical announces merger with starion instruments
Beverly, Massachusetts—Microline Surgical, a leading manufacturer of reposable instruments for minimally invasive surgery, announced that it has completed the merger of Starion Instruments™ Corp, a developer of surgical technology for sealing and dividing soft tissue. The merger enables Microline to fully leverage Starion’s manufacturing, research and development, customer service and financial operations and sets the stage for future expansion.

Through strategic acquisitions and organic growth, Microline Surgical has extended its offerings and strengthened its leadership position in the surgical marketplace. A global medical device manufacturer headquartered in Beverly, Massachusetts., Microline has sales in over 60 countries throughout North and South America, Europe, the Middle East and Asia.

According to Sharad Joshi, Microline’s president and chief operating officer, the integration of Starion’s operations opens the door to future expansion into new clinical areas and markets.

For more informaiton, please visit


Category: News and Trends, Past Articles

Comments are closed.